Disposition (code F) of 10,885 shares at $27.47 per share.
Reporting Person Hammes Eric D. · Officer Title Chief Financial Officer · Transaction Code F
Traded Aug 25, 2026 · Disclosed Aug 27, 2026
Source: SEC Form 4 · 0001610493-26-000009 · filed 2026-08-27 · View filing →
Disposition (code F) of 5,147 shares at $27.47 per share.
Reporting Person Befidi Robert · Officer Title President, Diagnostics · Transaction Code F
Traded Aug 25, 2026 · Disclosed Aug 27, 2026
Source: SEC Form 4 · 0002012361-26-000007 · filed 2026-08-27 · View filing →
Disposition (code F) of 804 shares at $27.47 per share.
Reporting Person Nilsson Stefan · Officer Title President, Nobel Biocare · Transaction Code F
Traded Aug 25, 2026 · Disclosed Aug 27, 2026
Source: SEC Form 4 · 0002045818-26-000005 · filed 2026-08-27 · View filing →
Disposition (code F) of 7,710 shares at $27.47 per share.
Reporting Person Acurio Veronica · Officer Title President, Orthodontics · Transaction Code F
Traded Aug 25, 2026 · Disclosed Aug 27, 2026
Source: SEC Form 4 · 0002045846-26-000007 · filed 2026-08-27 · View filing →
Sale of 8,000 shares at $27.50 per share.
Reporting Person Reis Mischa · Officer Title SVP, Strategy & Bus. Dev. · Transaction Code S
Traded Aug 20, 2026 · Disclosed Aug 24, 2026
Source: SEC Form 4 · 0001788632-26-000009 · filed 2026-08-24 · View filing →
Acquisition (code A) of 179,730 shares at $0 per share.
Reporting Person Keel Paul A · Officer Title Chief Executive Officer · Transaction Code A
Traded Aug 18, 2026 · Disclosed Aug 20, 2026
Source: SEC Form 4 · 0001626337-26-000010 · filed 2026-08-20 · View filing →